Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Integrum AB
AB
Active
Org 5564073145
Gemenskapens Gata 9, 431 53
Mölndal
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1990 · 35 years old
27 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Integrum AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
JO
Johan Olof Palmgren
Chief Auditor
Chief Auditor
2020
LM
Lars Martin Hillsten
Chief Executive Officer
Chief Executive Officer
2025
Former (2)
SD
Scott Dunning Flora
Chief Executive Officer
Chief Executive Officer
2024 – 2025
ME
Maria Elena Lopez Damian
Chief Executive Officer
Chief Executive Officer
2020 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (6)
AC
Anette Catharina Helén Lindqvist
Board of Directors
Board of Directors
2025
JH
John Henric Carlsson
Board of Directors
Board of Directors
2025
PR
Per Rickard Brånemark
Chairman
Chairman
2025
JF
Jens Fredrik Roland Rundqvist
Board of Directors
Board of Directors
2025
TV
Torben Vedel Stahl Jørgensen
Board of Directors
Board of Directors
2025
KB
Karl Bertil Kristofer Westergren
Board of Directors
Board of Directors
2025
Former (6)
AB
Artur Bernardino Aira
Board of Directors
Board of Directors
2023 – 2023
KH
Karin Helena Johansson Wingstrand
Board of Directors
Board of Directors
2020 – 2025
AM
Andrew Michael Christensen
Board of Directors
Board of Directors
2020 – 2025
CK
Cecilia Karin Maria Wikström
Board of Directors
Board of Directors
2022 – 2025
JP
Jonas Patric Lindgren
Board of Directors
Board of Directors
2020 – 2024
BS
Bengt Sjöholm
Chairman
Chairman
2020 – 2025
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Pericardium AB
Company
55%
55%
0001
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Integrum AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network